NetworkNewsBreaks

WednesdayNov 17, 2021 11:12 am

NetworkNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Featured in ROTH Equity Research Report

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We are reiterating our Buy rating and C$3/share 12-month price target on Mydecine following the release of 3Q21 results. . . The highlight of the quarter was the announcement that Mydecine plans to continue clinical research that was initiated a number of years ago at Johns Hopkins University, under the leadership of Dr. Matthew Johnson, a world-renowned psychedelic drug researcher. In a small, preliminary, open-label pilot study (n=15), it was shown that 80% of the subjects…

Continue Reading

WednesdayNov 17, 2021 10:55 am

NetworkNewsBreaks – Roth Capital Chooses IBN as Official Media Sponsor for Technology & AgTech Virtual Event

Roth Capital Partners has partnered with InvestorBrandNetwork (“IBN”) for its upcoming 10th annual Roth Technology & Inaugural AgTech Answers virtual event. IBN is an innovative corporate communications firm and content distributor. The two companies have worked together for several years with IBN serving as the conference media sponsor, focused on creating greater visibility for the event through nationally distributed press releases and its syndication network of more than 5,000 downstream publishers, including Apple News, MarketWatch and International Business Times. The three-day virtual conference is scheduled for Nov. 16–18, 2021 and will provide participants with a one-of-a-kind opportunity to learn about…

Continue Reading

WednesdayNov 17, 2021 10:44 am

NetworkNewsBreaks – deadmau5 Announces Release of head5 Collaboration with Smearballs

deadmau5, one of the world’s most respected electronic music producers of modern times, has released its latest NFT collectible project. Working in collaboration with Smearballs, deadmau5 has announced that the collection, called head5, covers numerous aspects of the digital space, including music, video games, literature, NFTs and more and is available for a limited time on the Polygon blockchain. Deadmau5, or Joel Zimmerman, and Smearballs, or Nick denBoer, have worked together previously, with Smearballs facilitating many of deadmau5’s tour visuals, including dancing bug-eyed farm animals, as well as characters in the music videos “Monophobia,” Pomegranate” and “Drama Free.” According to the…

Continue Reading

WednesdayNov 17, 2021 10:00 am

NetworkNewsBreaks – Clarus Corporation (NASDAQ: CLAR) closes on $85M Public Offering

Clarus Corporation (NASDAQ: CLAR), a leading designer, developer, manufacturer and distributor of best-in-class outdoor equipment and lifestyle products, announced that it has completed a previously announced underwritten public offering. The offering, which  resulted in $85 million in gross proceeds for the company, was comprised of 3,162,500 shares of CLAR common stock, including 412,500 shares pursuant to the full exercise of the over-allotment option granted to the underwriters. According to the company, the shares were sold at $27 per share. The company plans to use the net proceeds for repayment of debt, capital expenditures and potential acquisitions as well as other…

Continue Reading

TuesdayNov 16, 2021 3:50 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) on Track to Create Viable Fossil Fuels Replacement

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) offers an alternative solution to hydrogen distribution and storage issues through its proprietary on-site production of carbon-free ammonia (“NH3”) technology. The system is more energy efficient than conventional forms of NH3 production and does not emit CO2. “FuelPositive’s flagship modular and scalable carbon-free ammonia technology was developed by Dr. Ibrahim Dincer and his esteemed team at Ontario Technology University in Toronto. The platform will allow for in-situ production of NH3 sustainably. The process involves using only water, air and sustainable electricity,” reads a recent article. “Through its proprietary technology, FuelPositive is on track to create…

Continue Reading

TuesdayNov 16, 2021 3:37 pm

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) on Mission to Change How Consumers Define ‘Plant-Based’

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is driven by the objective to become the most-trusted name for people living plant-based lifestyles. The company provides a multifaceted marketplace offering plant-based products and services for consumers. “PlantX is on a mission to change how consumers define ‘plant-based’ by bringing together community, lifestyle and food,” reads a recent article. “Educating the public on how plant-based products can impact society is largely part of PlantX’s mission. The company works with the communities it serves to increase awareness and provide community members with the knowledge and education needed to understand the opportunities…

Continue Reading

TuesdayNov 16, 2021 3:03 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Working on Answer to Mass Production of Rare, Otherwise Depleted Cannabinoid Opportunities

InMed Pharmaceuticals (NASDAQ: INM) and its subsidiary BayMedica are innovators in the field of rare cannabinoids, making them available for consumer access. InMed specializes in developing a proprietary biosynthesis system to manufacture pharmaceutical-grade cannabinoids that are otherwise too rare to be acquired in abundance. Through BayMedica, its recent acquisition, InMed also has capabilities in both yeast biosynthesis and chemical synthesis, catering to the large and growing health and wellness consumer markets. “The cannabis plant is made up of over 100 unique cannabinoids, many of which are only found in trace amounts,” reads a recent article. “With so many of these…

Continue Reading

TuesdayNov 16, 2021 2:33 pm

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) Names New Chief Marketing Officer

GreenBox (NASDAQ: GBOX), an emerging fintech company leveraging proprietary blockchain security and token technology to build customized payment solutions, has appointed Jacqueline B. Reynolds as the company’s new chief marketing officer. In her new role, Reynolds will lead all marketing strategy, including the development of GreenBox’s brand positioning and communications plan. Reynolds served most recently as vice president of marketing for Sprouts Farmers Market, and she brings decades of experience with some of the world’s most coveted brands. She has built a reputation as a world-class global marketer, working with Coca-Cola, McDonalds, Verizon, Walmart, L’Oreal, Xbox, 7-Eleven and many other Fortune…

Continue Reading

TuesdayNov 16, 2021 2:26 pm

NetworkNewsBreaks – Numinus Wellness Inc. (TSX.V: NUMI) Advances MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials

Numinus Wellness (TSX.V: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, recently announced that it has secured two new Canadian psychedelic clinics to host the Canadian sites of the MAPS Public Benefit Corporation (MAPS PBC) study “A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD (MAPPUSX).” Per the release, the two new clinics are fully compliant with Health Canada regulations and ready to provide MDMA-assisted therapy as part of the trial. The Montreal and Vancouver sites, hosted by Numinus, will continue to advance the study of the safety and efficacy of MDMA in treating severe PTSD, under…

Continue Reading

TuesdayNov 16, 2021 2:20 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Roundtable

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at the Virtual Investor Roundtable Event, scheduled for Nov. 18, 2021. The CNSP overview, presented by CNS Pharmaceuticals CEO John Climaco and chief medical officer Sandra L. Silberman, MD, PhD. will begin at 9 a.m. ET. The presentation will be followed by a moderated roundtable discussion with time also included for questions and answers, which may be submitted by investors and interested parties during the live event. Questions may also be submitted…

Continue Reading